Self-renewal related signaling in myeloid leukemia stem cells

International Journal of Hematology

Volumn 94, Issue 2, 2011, Pages 109-117

  Heidel, Florian H ^a,b,c   Mar, Brenton G ^a,b   Armstrong, Scott A ^a,b,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

FoxO; Hedgehog; Leukemia stem cell; Notch; Self renewal; Wnt

Indexed keywords

ACETYLSALICYLIC ACID; BETA CATENIN; BMS 833923; CELECOXIB; CURCUMIN; DASATINIB; FORKHEAD TRANSCRIPTION FACTOR; GAMMA SECRETASE INHIBITOR; ICG 001; IPI 926; MK 0752; NONSTEROID ANTIINFLAMMATORY AGENT; NOTCH RECEPTOR; NVP LDE 225; NVP LEQ 506; PF 03084014; PF 04449913; POLYPHENOL DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN INHIBITOR; R 04929097; RESVERATROL; RETINOID DERIVATIVE; SEMAGACESTAT; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VISMODEGIB; VITAMIN; WNT PROTEIN; XAV 939;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; DRUG TARGETING; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; MYELOID LEUKEMIA; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; HUMANS; LEUKEMIA, MYELOID; MOLECULAR TARGETED THERAPY; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 80052376051     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0901-0     Document Type: Article

References (78)

1. T Lapidot, et al. 1994 A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 6464 645 648 7509044 10.1038/367645a0 1:STN:280:DyaK2c7ltVKrsg%3D%3D (Pubitemid 24067706)
2. D Bonnet JE Dick 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 7 730 737 9212098 10.1038/nm0797-730 1:CAS:528:DyaK2sXkt1GrtLY%3D (Pubitemid 27298715)
3. KJ Hope L Jin JE Dick 2004 Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity Nat Immunol 5 7 738 743 15170211 10.1038/ni1080 1:CAS:528:DC%2BD2cXlt1Wmuro%3D (Pubitemid 39023306)
4. A Cozzio, et al. 2003 Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors Genes Dev 17 24 3029 3035 14701873 10.1101/gad.1143403 1:CAS:528:DC%2BD2cXhs1ShsQ%3D%3D (Pubitemid 38040767)
5. BJ Huntly, et al. 2004 MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors Cancer Cell 6 6 587 596 15607963 10.1016/j.ccr.2004.10.015 1:CAS:528:DC%2BD2MXktVanug%3D%3D (Pubitemid 40017702)
6. AV Krivtsov, et al. 2006 Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9 Nature 442 7104 818 822 16862118 10.1038/nature04980 1:CAS:528:DC%2BD28XotFKmtr0%3D (Pubitemid 44258912)
7. TC Somervaille ML Cleary 2006 Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Cancer Cell 10 4 257 268 17045204 10.1016/j.ccr.2006.08.020 1:CAS:528:DC%2BD28XhtFCgsbjM (Pubitemid 44512188)
8. B Lowenberg, et al. 1998 Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy-the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group J Clin Oncol 16 3 872 881 9508168 1:CAS:528: DyaK1cXitVKis7g%3D (Pubitemid 28115455)
9. RM Stone, et al. 1995 Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia N Engl J Med 332 25 1671 1677 7760868 10.1056/NEJM199506223322503 1:STN:280:DyaK2M3otV2ktA%3D%3D
10. RJ Mayer, et al. 1994 Intensive postremission chemotherapy in adults with acute myeloid leukemia N Engl J Med 331 14 896 903 8078551 10.1056/ NEJM199410063311402 1:STN:280:DyaK2czlvFGluw%3D%3D (Pubitemid 24299870)
11. J Cortes, et al. 2011 Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia J Clin Oncol 29 5 524 531 21220597 10.1200/JCO.2010.31.3619 1:CAS:528:DC%2BC3MXjtFCjt74%3D
12. FX Mahon, et al. 2010 Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial Lancet Oncol 11 11 1029 1035 20965785 10.1016/S1470-2045(10)70233-3 1:CAS:528:DC%2BC3cXhtlKmtrnP
13. P Rousselot, et al. 2007 Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years Blood 109 1 58 60 16973963 10.1182/blood-2006-03-011239 1:CAS:528:DC%2BD2sXivVyrtL4%3D (Pubitemid 46053043)
14. PW Ingham AP McMahon 2001 Hedgehog signaling in animal development: paradigms and principles Genes Dev 15 23 3059 3087 11731473 10.1101/gad.938601 1:CAS:528:DC%2BD3MXptVKms7s%3D (Pubitemid 33115673)
15. C Nusslein-Volhard E Wieschaus 1980 Mutations affecting segment number and polarity in Drosophila Nature 287 5785 795 801 6776413 10.1038/287795a0 1:STN:280:DyaL3M%2Flt1ersQ%3D%3D (Pubitemid 11214475)
16. S Ahn AL Joyner 2005 In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog Nature 437 7060 894 897 16208373 10.1038/nature03994 1:CAS:528:DC%2BD2MXhtVKlsLnF (Pubitemid 41486765)
17. PA Beachy SS Karhadkar DM Berman 2004 Tissue repair and stem cell renewal in carcinogenesis Nature 432 7015 324 331 15549094 10.1038/nature03100 1:CAS:528:DC%2BD2cXpvVCjtb4%3D (Pubitemid 39551660)
18. J Lee, et al. 1997 Gli1 is a target of Sonic hedgehog that induces ventral neural tube development Development 124 13 2537 2552 9216996 1:CAS:528:DyaK2sXks1artLg%3D (Pubitemid 27341754)
19. MS Ikram, et al. 2004 GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter J Invest Dermatol 122 6 1503 1509 15175043 10.1111/j.0022-202X.2004.22612.x 1:CAS:528: DC%2BD2cXkvFCqtbk%3D (Pubitemid 38757234)
20. S Teglund R Toftgard 2010 Hedgehog beyond medulloblastoma and basal cell carcinoma Biochim Biophys Acta 1805 2 181 208 20085802 1:CAS:528: DC%2BC3cXjt1KqsrY%3D
21. XM Zhang M Ramalho-Santos AP McMahon 2001 Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R symmetry by the mouse node Cell 106 2 781 792 11517919 10.1016/S0092-8674(01)00385-3 1:STN:280:DC%2BD3MvnsVansg%3D%3D (Pubitemid 32635107)
22. C Dierks, et al. 2008 Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation Cancer Cell 14 3 238 249 18772113 10.1016/j.ccr.2008.08.003 1:CAS:528:DC%2BD1cXhtFKnu73J
23. J Gao, et al. 2009 Hedgehog signaling is dispensable for adult hematopoietic stem cell function Cell Stem Cell 4 6 548 558 19497283 10.1016/j.stem.2009.03.015 1:CAS:528:DC%2BD1MXnt1Ggtbw%3D
24. I Hofmann, et al. 2009 Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis Cell Stem Cell 4 6 559 567 19497284 10.1016/j.stem.2009.03.016 1:CAS:528:DC%2BD1MXnt1Ggtbo%3D
25. C Zhao, et al. 2009 Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia Nature 458 7239 776 779 19169242 10.1038/nature07737 1:CAS:528:DC%2BD1MXht1egsrY%3D
26. Irvine DA, et al. Combination of Hedgehog pathway inhibitor LDE225 and Nilotinib eliminates chronic myeloid leukemia stem and progenitor cells. Blood (ASH). 2009 (abstract no. 1428).
27. Zhang B, et al. Inhibition of chronic myeloid leukemia stem cells by the combination of the Hoedgehog pathway inhibitor LDE225 with Nilotinib. Blood (ASH). 2010 (abstract no. 514).
28. Schairer A, et al. Human blast crisis leukemia stem cell inhibition with a novel smoothened antagonist. Blood (ASH). 2010 (abstract no. 1223).
29. J Behrens, et al. 1998 Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta Science 280 5363 596 599 9554852 10.1126/science.280.5363.596 1:CAS:528:DyaK1cXjtVahs7o%3D (Pubitemid 28227764)
30. B Rubinfeld, et al. 1996 Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly Science 272 5264 1023 1026 8638126 10.1126/science.272.5264.1023 1:CAS:528:DyaK28XjtVejsrs%3D (Pubitemid 26259322)
31. K Tamai, et al. 2000 LDL-receptor-related proteins in Wnt signal transduction Nature 407 6803 530 535 11029007 10.1038/35035117 1:STN:280:DC%2BD3cvnslKgtQ%3D%3D
32. J Mao, et al. 2001 Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway Mol Cell 7 4 801 809 11336703 10.1016/S1097-2765(01)00224-6 1:CAS:528:DC%2BD3MXjsVentL0%3D (Pubitemid 32436440)
33. B Mao, et al. 2001 LDL-receptor-related protein 6 is a receptor for Dickkopf proteins Nature 411 6835 321 325 11357136 10.1038/35077108 1:CAS:528:DC%2BD3MXjvF2qtbo%3D (Pubitemid 32467039)
34. WJ Nelson R Nusse 2004 Convergence of Wnt, beta-catenin, and cadherin pathways Science 303 5663 1483 1487 15001769 10.1126/science.1094291 1:CAS:528:DC%2BD2cXhslCgsbo%3D (Pubitemid 38314410)
35. H Haegel, et al. 1995 Lack of beta-catenin affects mouse development at gastrulation Development 121 11 3529 3537 8582267 1:CAS:528:DyaK2MXps1aktb4%3D (Pubitemid 3000446)
36. HE Fleming, et al. 2008 Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo Cell Stem Cell 2 3 274 283 18371452 10.1016/j.stem.2008.01.003 1:CAS:528: DC%2BD1cXjslegtrg%3D (Pubitemid 351298592)
37. C Zhao, et al. 2007 Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo Cancer Cell 12 6 528 541 18068630 10.1016/j.ccr.2007.11.003 1:CAS:528:DC%2BD2sXhsVGmu73P (Pubitemid 350199070)
38. U Koch, et al. 2008 Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis Blood 111 1 160 164 17855627 10.1182/blood-2007-07-099754 1:CAS:528:DC%2BD1cXjtVKjsg%3D%3D
39. Y Hu, et al. 2009 beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia Leukemia 23 1 109 116 18818703 10.1038/leu.2008.262 1:CAS:528:DC%2BD1MXkvVaquw%3D%3D
40. Heidel FH, et al. Beta-catenin (Ctnnb1) suppression targets imatinib resistant leukemia stem cells in mice with BCR-ABL induced myeloproliferative disease. Blood (ASH). 2010 (annual meeting abstracts).
41. CH Jamieson, et al. 2004 Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML N Engl J Med 351 7 657 667 15306667 10.1056/NEJMoa040258 1:CAS:528:DC%2BD2cXms1Oktbg%3D (Pubitemid 39063268)
42. AE Abrahamsson, et al. 2009 Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation Proc Natl Acad Sci USA 106 10 3925 3929 19237556 10.1073/pnas.0900189106 1:CAS:528:DC%2BD1MXjt1Gktr0%3D
43. Y Wang, et al. 2010 The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML Science 327 5973 1650 1653 20339075 10.1126/science.1186624 1:CAS:528:DC%2BC3cXjslaqsLw%3D
44. J Yeung, et al. 2010 beta-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells Cancer Cell 18 6 606 618 21156284 10.1016/j.ccr.2010.10.032 1:CAS:528:DC%2BC3cXhsFGhsbvF
45. TE North, et al. 2009 Hematopoietic stem cell development is dependent on blood flow Cell 137 4 736 748 19450519 10.1016/j.cell.2009.04.023 1:CAS:528:DC%2BD1MXosVClt7s%3D
46. W Goessling, et al. 2009 Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration Cell 136 6 1136 1147 19303855 10.1016/j.cell.2009.01.015 1:CAS:528:DC%2BD1MXltFSnt7o%3D
47. CJ Eaves RK Humphries 2010 Acute myeloid leukemia and the Wnt pathway N Engl J Med 362 24 2326 2327 20554989 10.1056/NEJMcibr1003522 1:CAS:528:DC%2BC3cXnvVakurY%3D
48. Z Tothova DG Gilliland 2007 FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system Cell Stem Cell 1 2 140 152 18371346 10.1016/j.stem.2007.07.017 1:CAS:528:DC%2BD2sXhtVSnsrvI (Pubitemid 47215597)
49. Z Tothova, et al. 2007 FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress Cell 128 2 325 339 17254970 10.1016/j.cell.2007.01.003 1:CAS:528:DC%2BD2sXhsVOqsr0%3D (Pubitemid 46137992)
50. K Miyamoto, et al. 2007 Foxo3a is essential for maintenance of the hematopoietic stem cell pool Cell Stem Cell 1 1 101 112 18371339 10.1016/j.stem.2007.02.001 1:CAS:528:DC%2BD2sXptV2rs70%3D (Pubitemid 46865800)
51. K Naka, et al. 2010 TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia Nature 463 7281 676 680 20130650 10.1038/nature08734 1:CAS:528:DC%2BC3cXhsVygtL4%3D
52. Sykes SM, et al. The AKT/FOXO signaling pathway is required for the maintenance of acute myeloid leukemia. Cell. 2011 (in press).
53. AW Duncan, et al. 2005 Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance Nat Immunol 6 3 314 322 15665828 10.1038/ni1164 1:CAS:528:DC%2BD2MXhtleqt78%3D (Pubitemid 41724769)
54. M Wu, et al. 2007 Imaging hematopoietic precursor division in real time Cell Stem Cell 1 5 541 554 18345353 10.1016/j.stem.2007.08.009 1:CAS:528:DC%2BD2sXhsVahtrvE (Pubitemid 350056405)
55. D Allman JC Aster WS Pear 2002 Notch signaling in hematopoiesis and early lymphocyte development Immunol Rev 187 75 86 12366684 10.1034/j.1600-065X.2002. 18707.x 1:CAS:528:DC%2BD38XosFegsrk%3D (Pubitemid 35176815)
56. S Artavanis-Tsakonas K Matsuno ME Fortini 1995 Notch signaling Science 268 5208 225 232 7716513 10.1126/science.7716513 1:CAS:528:DyaK2MXltVCitLg%3D
57. L Wu, et al. 2000 MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors Nat Genet 26 4 484 489 11101851 10.1038/82644 1:CAS:528:DC%2BD3cXptVWgt70%3D
58. B Varnum-Finney, et al. 2000 Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling J Cell Sci 113 Pt 23 4313 4318 11069775 1:CAS:528:DC%2BD3MXotlag (Pubitemid 32000694)
59. PM Chen, et al. 2008 Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia Int J Oncol 32 6 1335 1341 18497996 1:CAS:528:DC%2BD1cXns1ans7c%3D
60. F Nakahara, et al. 2010 Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia Blood 115 14 2872 2881 19861684 10.1182/blood-2009-05-222836 1:CAS:528:DC%2BC3cXkvFKhsrw%3D
61. A Klinakis, et al. 2011 A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia Nature 473 7346 230 233 21562564 10.1038/nature09999 1:CAS:528:DC%2BC3MXlvFGmtb0%3D
62. KJ Hope, et al. 2010 An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity Cell Stem Cell 7 1 101 113 20621054 10.1016/j.stem.2010.06.007 1:CAS:528: DC%2BC3cXps12kt78%3D
63. T Ito, et al. 2010 Regulation of myeloid leukaemia by the cell-fate determinant Musashi Nature 466 7307 765 768 20639863 10.1038/nature09171 1:CAS:528:DC%2BC3cXovFCnsrg%3D
64. MG Kharas, et al. 2010 Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia Nat Med 16 8 903 908 20616797 10.1038/nm.2187 1:CAS:528:DC%2BC3cXosFeltb0%3D
65. M Okabe, et al. 2001 Translational repression determines a neuronal potential in Drosophila asymmetric cell division Nature 411 6833 94 98 11333984 10.1038/35075094 1:CAS:528:DC%2BD3MXjsFGmur8%3D (Pubitemid 32428196)
66. NIH. http://www.clinicaltrials.gov.
67. RA Gupta RN Dubois 2001 Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat Rev Cancer 1 1 11 21 11900248 10.1038/35094017 1:STN:280:DC%2BD387mvVOhsA%3D%3D (Pubitemid 33741877)
68. PM Rothwell, et al. 2010 Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Lancet 376 9754 1741 1750 20970847 10.1016/S0140-6736(10)61543-7 1:CAS:528: DC%2BC3cXhsVGitbfF
69. Rothwell PM, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377(9759):31-41.
70. S Shah, et al. 2003 Trans-repression of beta-catenin activity by nuclear receptors J Biol Chem 278 48 48137 48145 12972427 10.1074/jbc.M307154200 1:CAS:528:DC%2BD3sXpt1GjsLY%3D (Pubitemid 37523266)
71. AS Jaiswal, et al. 2002 Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells Oncogene 21 55 8414 8427 12466962 10.1038/sj.onc.1205947 1:CAS:528:DC%2BD38Xpt1Wit70%3D (Pubitemid 36061200)
72. AM Roccaro, et al. 2008 Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia Clin Cancer Res 14 6 1849 1858 18347188 10.1158/1078-0432.CCR-07-1750 1:CAS:528:DC%2BD1cXjtleisrg%3D (Pubitemid 351469472)
73. F Takahashi-Yanaga M Kahn 2010 Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 16 12 3153 3162 20530697 10.1158/1078-0432.CCR-09-2943 1:CAS:528:DC%2BC3cXntlKru7o%3D
74. SM Huang, et al. 2009 Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling Nature 461 7264 614 620 19759537 10.1038/nature08356 1:CAS:528:DC%2BD1MXhtFentbzP
75. L You, et al. 2004 An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth Cancer Res 64 15 5385 5389 15289346 10.1158/0008-5472.CAN-04-1227 1:CAS:528:DC%2BD2cXmtF2mu7w%3D (Pubitemid 39006560)
76. L You, et al. 2004 Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells Cancer Res 64 10 3474 3478 15150100 10.1158/0008-5472.CAN-04-0115 1:CAS:528:DC%2BD2cXktVWhsLo%3D (Pubitemid 38657920)
77. VI DeAlmeida, et al. 2007 The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo Cancer Res 67 11 5371 5379 17545618 10.1158/0008-5472.CAN-07-0266 1:CAS:528:DC%2BD2sXmtVait7s%3D (Pubitemid 46997277)
78. T Hoey, et al. 2009 DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency Cell Stem Cell 5 2 168 177 19664991 10.1016/j.stem.2009.05.019 1:CAS:528:DC%2BD1MXhsVCiu77P